Wikidata

(Q58024790)

English

Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors

article published in 2010

In more languages

Statements

title
Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors (English)
0 references
author name string
R. Kefford
series ordinal
1
0 references
H. Arkenau
series ordinal
2
0 references
M. P. Brown
series ordinal
3
0 references
M. Millward
series ordinal
4
0 references
J. R. Infante
series ordinal
5
0 references
G. V. Long
series ordinal
6
0 references
D. Ouellet
series ordinal
7
0 references
M. Curtis
series ordinal
8
0 references
P. F. Lebowitz
series ordinal
9
0 references
G. S. Falchook
series ordinal
10
0 references
publication date
20 May 2010
0 references
volume
28
0 references
page(s)
8503-8503
0 references
issue
15_suppl
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q58024790&oldid=1876869159"